ABCC2 gene variants contribute to susceptibility to nonalcoholic fatty liver disease (NAFLD) (Sookoian et al., 2009), which is prevalent in cases of NAFLD with cirrhosis, high BMI, and psychiatric disorders involving opioid use (Moon et al., 2021). The gene discussed is ABCC2; the disease is metabolic dysfunction-associated steatotic liver disease.